Results 41 to 50 of about 4,692,466 (299)

Discrepancy of contrast-enhanced ultrasonographic pattern with two contrast agents in steatohepatitic subtype hepatocellular carcinoma: A case report

Radiology Case Reports, 2022
Contrast-enhanced ultrasound (CEUS) is one of the important imaging modalities for diagnosis of hepatocellular carcinoma (HCC). Sonovue and Sonazoid are the third-generation of ultrasound contrast agents that have been commercialized and widely used in ...
Jiang Bo, MD, Kong BeiNing, PhD, Fei Xiang, MD, PhD, Wan XinKun, MD, Luo YuKun, MD, PhD   +4 more
doaj   +1 more source

Anaesthesia Fluid Detection in 3D Contrast Enhanced Ultrasound Image [PDF]

, 2011
Ultrasound medical image has disadvantage on displaying anaesthesia fluid due to its low intensity. Using contrast agent to enhance brightness of fluid area makes it possible to extract fluid area from acquired 3D image. This paper proposes
Alkaff, Dalily
core  

Contrast-Enhanced Ultrasound for Musculoskeletal Applications: A World Federation for Ultrasound in Medicine and Biology Position Paper [PDF]

, 2020
This World Federation for Ultrasound in Medicine and Biology position paper reviews the diagnostic potential of ultrasound contrast agents for clinical decision-making and provides general advice for optimal contrast-enhanced ultrasound performance in ...
Dietrich, Christoph Frank, Jung, Ernst Michael, Loizides, Alexander, Radzina, Maija, Jung, Ernst-Michael, Fischer, Christian, Krix, Martin, Klauser, Andrea, Weber, Marc-André, Weber, Marc André, Gruber, Hannes   +10 more
core   +1 more source

Preoperative circulating tumor cells integrated with imaging analysis for prognostic evaluation in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach, Gizem Abaci, Tom Huberty, Axel Lechner, Lukas Käsmann, Jens Ricke, Sophia Stöcklein, Martin Canis, Philipp Baumeister, Marianna Alunni‐Fabbroni   +9 more
wiley   +1 more source

Contrast enhanced ultrasound in mixed hepatocellular cholangiocarcinoma: Case series and review of the literature. [PDF]

, 2018
BACKGROUND Mixed hepatocellular cholangiocarcinoma is a rare form of primary liver cancer. AIMS The aim of this study is to report the results of the use of contrast enhanced ultrasound in a series of patients with confirmed mixed hepatocellular
Dong, Yi, Cui, Xin Wu, Annalisa Berzigotti, Berzigotti, Annalisa, Andreas Teufel, Christoph F. Dietrich, Teufel, Andreas, Trojan, Jörg, Xin Wu Cui, Dietrich, Christoph F, Jörg Trojan, Yi Dong, Teufel A, Dong Y, Trojan J, Dietrich CF, Berzigotti A, Cui XW   +17 more
core   +1 more source

Extracellular matrix remodeling and immune reprogramming drive residual tumor progression of liver cancer after incomplete microwave ablation

Molecular Oncology, EarlyView.
Incomplete microwave ablation (iMWA) of liver cancer triggers a biphasic progression in residual tumors. At Day 3, the microenvironment is characterized by acute inflammatory responses and extracellular matrix (ECM) remodeling. By Day 14, a profound shift occurs toward oncogenic signal transduction and immunosuppression, marked by macrophage ...
Yu Liu, Yubei He, Nikolaus Berndt, Michael Mülleder, Kathrin Textoris‐Taube, Jing Guo, Matthias Stechele, Justus Ramtke, Shraga Nahum Goldberg, Lynn Jeanette Savic   +9 more
wiley   +1 more source

Contrast-Enhanced Ultrasound (CEUS)

, 2021
Contrast-enhanced ultrasound (CEUS) imaging is a widely used medical imaging technique combining ultrasound and ultrasound contrast agents (UCAs) for clinical decision-making.
Harrie P. Beerlage, Wijkstra, Hessel, Massimo Mischi, Rogier R. Wildeboer, van Kollenburg, Rob A.A., Mannaerts, Christophe K., Hessel Wijkstra, Wildeboer, Rogier R., Christophe K. Mannaerts, Ruud J. G. van Sloun, Mischi, Massimo; id_orcid, Rob A. A. van Kollenburg, van Sloun, Ruud J.G.; id_orcid, Beerlage, Harrie P.   +13 more
core   +1 more source

Tumour‐proximal deep serum proteomics identifies biomarkers associated with ovarian cancer

Molecular Oncology, EarlyView.
New biomarkers are needed for early ovarian cancer detection. Ovarian (tumour‐proximal) and peripheral vein serum from healthy women and patients with benign or malignant tumours underwent nanoparticle‐enriched deep proteomics. Ovarian serum yielded more protein identifications and revealed tumour‐reflective signatures.
Darren Lau, Daniel Pincher, Clifford Young, Nicholas Chappell, Noor A. Lokman, Parul Mittal, Leigh Donnellan, Martin K. Oehler, Doug A. Brooks, Peter Hoffmann   +9 more
wiley   +1 more source

UiO‐66 metal–organic frameworks in biomedicine: From structural tunability to bioimaging, photodiagnostics, and photodynamic cancer therapy

FEBS Open Bio, EarlyView.
UiO‐66(Zr) metal–organic frameworks are chemically stable, biocompatible, and highly tunable nanomaterials. Their modular structure enables controlled drug delivery, multimodal bioimaging, and light‐activated photodynamic therapy, supporting integrated diagnostic and therapeutic (theranostic) applications in cancer and biomedical research.
Veronika Huntošová, Grigorii Rakhalskii, Miroslav Almáši   +2 more
wiley   +1 more source

Contrast-enhanced ultrasound for myocardial perfusion imaging.

, 2012
Ultrasound contrast agents are gas-filled microbubbles that enhance visualization of cardiac structures, function and blood flow during contrast-enhanced ultrasound (CEUS).
Bulte, Carolien S E, Boer, Christa, Meijer, Rick I, Gort, Dennis, Kamp, Otto, Bouwman, R Arthur, Vogel, Rolf, Loer, Stephan A, de Marchi, Stefano F., Slikkerveer, Jeroen, De Marchi, Stefano   +10 more
core   +1 more source